2025Financing AgreementsIn March, Zynext Ventures USA LLC invested in Illexcor Therapeutics. 2025New Products/ServicesIn February, the company unveiled VaxiFlu-4, a quadrivalent influenza vaccine for the 2025 southern hemisphere season, offering protection against four key flu strains. ...